Product image of Factor Vii Baxalta (Human Coagulation Factor Vii) supplied by GNH India

Factor Vii Baxalta

Active Ingredient:
Human Coagulation Factor Vii
Origin:
EU

Factor Vii Baxalta (Human Coagulation Factor Vii)

Human Coagulation Factor VII is a recombinant protein used to manage bleeding episodes in certain medical conditions. This intravenous medication supports blood clotting and is manufactured by Baxalta Innovations GmbH.

Manufacturer / TM Owner

Baxalta Innovations Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Human Coagulation Factor VII is primarily used to control bleeding in individuals with specific clotting disorders. It works by aiding the blood's natural clotting process, which can be impaired in certain conditions. This medication is often administered intravenously to address bleeding episodes promptly.

Side Effects

  • Common effects of Human Coagulation Factor VII may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild flu-like symptoms, including fever or chills. These effects are generally temporary and subside as the body adjusts to the medication.

Precautions & Warnings

  • Human Coagulation Factor VII should be handled with care, ensuring proper storage and administration as directed by a healthcare professional. It is essential to inform your healthcare provider about any allergies or pre-existing conditions before use. Always follow the prescribed guidelines for intravenous administration to minimize risks.

Avoid Interactions

  • Human Coagulation Factor VII may interact with other medications that affect blood clotting. It is crucial to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain medical conditions may influence the effectiveness or safety of this medication.

Frequently Asked Questions

Human Coagulation Factor VII is used to manage bleeding episodes in individuals with specific clotting disorders.

Human Coagulation Factor VII is typically administered intravenously by a healthcare professional.

Common effects may include localized reactions at the injection site and mild flu-like symptoms.

Human Coagulation Factor VII is manufactured by Baxalta Innovations GmbH.

Yes, it is important to inform your healthcare provider about any allergies or pre-existing conditions before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Vii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT